RBM39 splices VEGF isoforms in metastatic breast cancer cells and loss of RBM39 in sarcoma cells alters VEGF isoform ratio towards more mitogenic/angiogenic forms of VEGF19. This evidence concerns the gene VEGFA and sarcoma.